Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 12, 2001 - Issue 1
Submit an article Journal homepage
101
Views
32
CrossRef citations to date
0
Altmetric
Research Article

The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum

JH Hagman University of Rome Tor Vergata, Department of Dermatology, Rome, Italy
,
AM Carrozzo University of Rome Tor Vergata, Department of Dermatology, Rome, Italy
,
E Campione University of Rome Tor Vergata, Department of Dermatology, Rome, Italy
,
P Romanelli University of Miami School of Medicine, Department of Dermatology and Cutaneous Surgery, Miami, Florida, USA
&
S Chimenti University of Rome Tor Vergata, Department of Dermatology, Rome, Italy
Pages 19-22 | Published online: 12 Jul 2009

  • Powell FC, Su WPD, Perry HO, Pyoderma gangrenosum: classification and management J Am Acad Dermatol (1996) 34: 395-409.
  • Lear JT, Atherton MT, Byrne JPH, Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome. Postgrad Med J (1997) 73: 65-8.
  • Jorizzo JL, Solomon AR, Zanolli MD, Leshin B, Neutrophilic vascular reactions. J Am Acad Dematol (1988) 19: 983-1005.
  • Schaegerle SM, Bergfeld WF, Senitzer D, Tidrick RT, Pyoderma gangrenosum: a review. J Am Acad Dermatol (1988) 18: 559-68.
  • Gallen JP, Pyoderma gangrenosum. Lancet (1998) 351: 581-5.
  • Levitt MD, Ritchie JK, Leonard-Jones JE, Philips RKS, Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg (1991) 78: 676-8.
  • Hava H Wakvi F, Fujitsuka A et al, Subcutaneous abscesses in a patient with ulcerative colitis. J Am Acad Dermatol (2000) 42: 363-5.
  • Clark HH, Cohen PR, Pyoderma gangrenosum in an HIV-infected patient. J Am Acad Dermatol (1995) 32:912-14.
  • Graham JA. Hansen KK, Rabinowitz LG, Esterly NB. Pyoderma gangrenosum in infants and children. Pediatr Dermatol (1994) 11:10-18.
  • Glass AT, Bancila E, Milgraum S, Pyoderma gangrenosum in infancy: the youngest reported patient. J Am Acad Dermatol (1991) 25:109-10.
  • Chow RKP, Ho VC, Treatment of pyoderma gangrenosum. J Am Acad Dermatol (1996) 34:1047-60.
  • Von den Driesch P, Pyoderma gangrenosum: a case report of 44 cases with follow-up. Br J Dermatol (1997) 137: 1000-5.
  • Richter-Hintz D, Schuppe HC, Homey B et al, Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol (2000) 42: 304-5.
  • Wolf R, Nicotine for pyoderma gangrenosum. Arch Dermatol (1998) 134:1071-2.
  • Gupta AK, Shear NH, Sauder DN, Efficacy of human intravenous immunoglobuline in pyoderma gangrenosum. J Am Acad Dermatol (1995) 32:140-2
  • Dirscha T, Kastner U, Behrens S, Altmeyer P, Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. J Am Acad Dermatol (1998) 39: 789-90.
  • Dwyer JM, Manipulating the immune system with immune globulin. N Engl J Med(1992) 326:107-16.
  • Mouthon L, Kaveri SV, Spalter SH et al. Mechanism of action of intravenous immune globulin in immune mediated diseases. Clin Exp Immunol (1996) 104: 3-9.
  • Basta M Modulation of complement-mediated immune damage by intravenous immune globulin. Clin Exp Immunol (1996) 104:21-5.
  • Andersson J, Skansen-Saphir U, Sparrelid E, Andersson U, Intravenous immune globulin affects cytochine production in T lymphocytes and monocytes/macrophages. Clin Exp Immunol (1996) 104:10-20.
  • Gottfried I. Seeber A. Anegg B et al. Established and new therapeutic approaches in dermatomyositis, polimyositis and overlapping syndromes. Wien Klin Wochenschr (1996) 108: 705-76.
  • Jolies S, Huges J. Whittaker S, Dermatological uses of highdose intravenous immunoglobulin. Arch Dermatol (1998) 134: 80-6.
  • Messer G, Sizmann N, Feucht H, Meurer M High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris. Br J Dermatol (1995) 133: 1014-16.
  • Backers RC, Brand A, Vermeer BJ, Boom BW, Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. Br J Dermatol (1995) 133:289-93.
  • Mohr C, Sunderkotter C, Hildebrand A et al, Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins. Br J Dermatol (1995) 132: 824-6.
  • Sanwo M Nwadiuko R, Beall G, Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS. J Allergy Clin Immunol (1996) 98/6:1112-15.
  • Viard I. Wehrli P. Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science (1998) 282:490-3.
  • Kimata H, High-dose gammaglobulin treatment for atopic dermatitis. Arch Dis Child(1994) 70: 335-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.